Author/Authors :
İlhan, Özgür Mustafa Kemal Üniversitesi - Tıp Fakültesi - Göz Hastalıkları Ana Bilim Dalı, Türkiye , Coşkun, Mesut Mustafa Kemal Üniversitesi - Tıp Fakültesi - Göz Hastalıkları Ana Bilim Dalı, Türkiye , İlhan, Nilüfer Mustafa Kemal Üniversitesi - Tıp Fakültesi - Göz Hastalıkları Ana Bilim Dalı, Türkiye , Ayıntap, Emre Mustafa Kemal Üniversitesi - Tıp Fakültesi - Göz Hastalıkları Ana Bilim Dalı, Türkiye , Keskin, Uğurcan Mustafa Kemal Üniversitesi - Tıp Fakültesi - Göz Hastalıkları Ana Bilim Dalı, Türkiye , Tuzcu, Esra Mustafa Kemal Üniversitesi - Tıp Fakültesi - Göz Hastalıkları Ana Bilim Dalı, Türkiye , Öksüz, Hüseyin Mustafa Kemal Üniversitesi - Tıp Fakültesi - Göz Hastalıkları Ana Bilim Dalı, Türkiye
Abstract :
Objectives: The aim of this study was to investigate efficacy and safety of subtenon triamcinolone (ST) in combination with focal laser photocoagulation in diabetic macular edema (DME). Materials and methods: Medical records of patients with DME, treated with 40 mg subtenon injection of triamcinolone acetonid prior to focal laser photocoagulation were retrospectively analyzed. Seventeen eyes of 17 patients with DME were enrolled in the study. All patients underwent a comprehensive ophthalmological examination before the treatment. Efficacy of the treatment after ST injection was evaluated by visual acuity and flourescein angiography (FA). Follow-up visits were performed at 1st, 3rd, 6th and 12th months. Repeated measures ANOVA was used for statistical analysis. Results: The mean age was 61.5 ± 8.7 years and the mean visual acuity in the study eyes was 0.22 ± 0.13 before the treatment, 0.39 ± 0.15 at 1st month, 0.36 ± 0.18 at 3rd month, 0.33 ± 0.15 at 6th month and 0.34 ± 0.16 at 12th month. The differences in the visual acuity before the treatment and follow-up visits were significant (p 0.05). Visual acuity was increased in 13 (%76,4) patients, decreased in 1 (%5,8) and unchanged in 3 (%17,6). Conclusion: Injection of 40 mg of triamsinolon via subtenon route combined with focal laser photocoagulation is a safe and beneficial treatment in cases of DME.
